What's new

CVMP recommendations on limited market classification and eligibility for authorisation under Article 23

CVMP recommendations on limited market classification and eligibility for authorisation under Article 23

Jun 19, 2025 - 11:05
 0
CVMP recommendations on limited market classification and eligibility for authorisation under Article 23
CVMP recommendations on limited market classification and eligibility for authorisation under Article 23
Read More

Tags:

Previous Article

Code of conduct of the European Medicines Agency

Next Article

Superseded Community herbal monograph on Zingiber officinale Roscoe, rhizoma

Related Posts

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn

Orphan designation: Resminostat Treatment of hepatocell...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0